Clearview Wealth Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-466
| Closed | -$2.41K | – | 452 |
|
|
2023
Q2 | $2.41K | Hold |
466
| – | – | ﹤0.01% | 505 |
|
|
2023
Q1 | $2.46K | Hold |
466
| – | – | ﹤0.01% | 496 |
|
|
2022
Q4 | $1.31K | Sell |
466
-288
| -38% | -$809 | ﹤0.01% | 510 |
|
|
2022
Q3 | $3K | Sell |
754
-321
| -30% | -$1.28K | ﹤0.01% | 461 |
|
|
2022
Q2 | $4K | Hold |
1,075
| – | – | ﹤0.01% | 450 |
|
|
2022
Q1 | $5K | Sell |
1,075
-182
| -14% | -$847 | ﹤0.01% | 453 |
|
|
2021
Q4 | $9K | Hold |
1,257
| – | – | 0.01% | 439 |
|
|
2021
Q3 | $13K | Hold |
1,257
| – | – | 0.01% | 385 |
|
|
2021
Q2 | $18K | Sell |
1,257
-719
| -36% | -$10.3K | 0.01% | 352 |
|
|
2021
Q1 | $32K | Buy |
1,976
+415
| +27% | +$6.72K | 0.02% | 277 |
|
|
2020
Q4 | $32K | Buy |
+1,561
| New | +$32K | 0.02% | 246 |
|